Insiders · Profile

Thomas Brian C.

Director at Metagenomi Therapeutics. Filing since 6 Jun 2025. CIK 0001996097

Company

Date

Role

Action

Shares

Amount

Of holding

MGX Metagenomi Therapeutics, Inc.

5 Dec 2025

Director

Sold at will

3,830

$6.79K

0.2%

MGX Metagenomi Therapeutics, Inc.

5 Sep 2025

Director

Sold at will

2,701

$4.89K

0.1%

MGX Metagenomi Therapeutics, Inc.

6 Jun 2025

Chief Executive Officer

Sold at will

10,785

$18.87K

0.4%

3 decisions on file.